New patent expiration for Novartis drug GLEEVEC
Drug Patent Watch
JUNE 18, 2022
Annual Drug Patent Expirations for GLEEVEC Gleevec is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There is one patent protecting…. The post New patent expiration for Novartis drug GLEEVEC appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content